以上内容来自Benzinga Earnings专栏,原文如下:
Ekso Bionics Holdings (NASDAQ:EKSO) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate of $(0.07) by 100 percent. This is a 36.36 percent increase over losses of $(0.22) per share from the same period last year. The company reported quarterly sales of $5.09 million which beat the analyst consensus estimate of $5.05 million by 0.74 percent. This is a 5.01 percent increase over sales of $4.85 million the same period last year.
精彩评论